Shoba L. Subramanian, MD works in the field of Endocrinology. He received awards:"CMS Meaningful Use Stage 1 Certification". Shoba Subramanian is also a published MD. He has 6 paper published. The most recent paper is: One year of sitagliptin treatment protects against islet amyloid-associated -cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. Shoba L. Subramanian accepts Medicare.
NPI NUMBER | 1942493341 | |
NPPES Provider LastName | SUBRAMANIAN | |
NPPES Provider FirstName | SHOBA | |
NPPES Provider ZIPCode | 940402833 | |
NPPES Provider State | CA | |
Specialty Description | Endocrinology | |
Total Claim Count | 1127.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1942493341 |
Last Name Of The Provider | SUBRAMANIAN |
First Name Of The Provider | SHOBA |
View All |
![]() |
Dr. Rachael White, MD
![]() |
![]() |
Dr. Samira Kirmiz, MD
![]() |
![]() |
Dr. Preethi C. Sridhar, MD
![]() |
![]() |
Dr. Lynn J. Bennion, MD
![]() ![]() |
![]() |
Dr. Linda Membreno, MD
![]() |